does the va cover glp-1 drugs Medicare Bridge Program Explained: Medications for Weight Loss VAResearchNewsBrief: Orlando VA Healthcare System

A mean increase in HR of 1.86 beats/min was reported in a meta-analysis including available data from randomized controlled trials testing GLP-1 agonists against placebo in patients with T2D [53]

doi: 10.2337/db18-43-OR

The key question becomes whether the records support a link to one product, multiple products, or another cause, especially when symptoms overlap across drugs in the same class

[53] The trials were conducted at 673 sites in 24 countries, including Argentina, Australia, Brazil, Canada, India, Israel, Japan, Mexico, Russian Federation, South Korea, Taiwan, European Union, and the United States (including Puerto Rico)

Pratley et al., 2019